Display options
Cite
Sienkiewicz BM, Łapiński Ł, Wiela-Hojeńska A. Comparison of clinical pharmacology of voriconazole and posaconazole. Contemp Oncol (Pozn). 2016;20(5):365-373doi: 10.5114/wo.2016.64594.
Sienkiewicz, B. M., Łapiński, �. �., & Wiela-Hojeńska, A. (2016). Comparison of clinical pharmacology of voriconazole and posaconazole. Contemporary oncology (Poznan, Poland), 20(5), 365-373. https://doi.org/10.5114/wo.2016.64594
Sienkiewicz, Beata M, et al. "Comparison of clinical pharmacology of voriconazole and posaconazole." Contemporary oncology (Poznan, Poland) vol. 20,5 (2016): 365-373. doi: https://doi.org/10.5114/wo.2016.64594
Sienkiewicz BM, Łapiński Ł, Wiela-Hojeńska A. Comparison of clinical pharmacology of voriconazole and posaconazole. Contemp Oncol (Pozn). 2016;20(5):365-373. doi: 10.5114/wo.2016.64594. Epub 2016 Dec 20. PMID: 28373817; PMCID: PMC5371702.
Copy Download .nbib Format: NLM
Share it on

Contemp Oncol (Pozn). 2016;20(5):365-373. doi: 10.5114/wo.2016.64594. Epub 2016 Dec 20.

Comparison of clinical pharmacology of voriconazole and posaconazole.

Contemporary oncology (Poznan, Poland)

Beata M Sienkiewicz, Łukasz Łapiński, Anna Wiela-Hojeńska

Affiliations

  1. Wroclaw Medical University, Wroclaw, Poland.

PMID: 28373817 PMCID: PMC5371702 DOI: 10.5114/wo.2016.64594

Abstract

Despite greater knowledge and possibilities in pharmacotherapy, fungal infections remain a challenge for clinicians. As the population of immunocompromised patients and those treated for their hematologic ailments increases, the number of fungal infections grows too. This is why there is still a quest for new antifungal drugs as well as for optimization of pharmacotherapy with already registered pharmaceutics. Voriconazole and posaconazole are broad-spectrum, new generation, triazole antifungal agents. The drugs are used in the pharmacotherapy of invasive aspergillosis,

Keywords: clinical pharmacology; cytochrome P-450 enzyme system; drug monitoring; posaconazole; voriconazole

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. J Antimicrob Chemother. 2014 Jun;69(6):1633-41 - PubMed
  2. Pharmacogenet Genomics. 2012 Feb;22(2):159-65 - PubMed
  3. Antimicrob Agents Chemother. 2014 Nov;58(11):6879-85 - PubMed
  4. Mycoses. 2011 Nov;54(6):e877-9 - PubMed
  5. Can J Hosp Pharm. 2009 Nov;62(6):469-82 - PubMed
  6. Pharmacotherapy. 2011 Feb;31(2):214-25 - PubMed
  7. Jundishapur J Microbiol. 2015 Sep 08;8(9):e28057 - PubMed
  8. Mayo Clin Proc. 2011 Aug;86(8):805-17 - PubMed
  9. J Clin Microbiol. 2011 Sep;49(9):3300-8 - PubMed
  10. Antimicrob Agents Chemother. 2006 Sep;50(9):3227-8 - PubMed
  11. Eur J Med Res. 2011 Apr 28;16(4):139-44 - PubMed
  12. Antimicrob Agents Chemother. 2012 Jan;56(1):526-31 - PubMed
  13. Open Forum Infect Dis. 2015 Jul 04;2(3):ofv099 - PubMed
  14. Med Mycol. 2005 Feb;43(1):91-5 - PubMed
  15. Antimicrob Agents Chemother. 2012 Jun;56(6):2806-13 - PubMed
  16. Curr Fungal Infect Rep. 2015;9(2):122-129 - PubMed
  17. Clin Microbiol Rev. 2014 Jul;27(3):490-526 - PubMed
  18. Pharmacotherapy. 2013 Mar;33(3):e19-22 - PubMed
  19. Clin Infect Dis. 2010 Jan 1;50(1):27-36 - PubMed
  20. Expert Opin Investig Drugs. 2009 Sep;18(9):1279-95 - PubMed
  21. J Heart Lung Transplant. 2004 Dec;23(12):1451-4 - PubMed
  22. J Antimicrob Chemother. 2014 May;69(5):1162-76 - PubMed
  23. Ann Intern Med. 2014 Jul 15;161(2):JC8 - PubMed
  24. J Antimicrob Chemother. 2012 Mar;67(3):700-6 - PubMed
  25. J Antimicrob Chemother. 2008 Jan;61(1):17-25 - PubMed
  26. Clin Infect Dis. 2007 Dec 15;45(12):1610-7 - PubMed
  27. Antimicrob Agents Chemother. 2009 Jan;53(1):24-34 - PubMed
  28. Antimicrob Agents Chemother. 2009 Mar;53(3):935-44 - PubMed
  29. New Microbes New Infect. 2015 Apr 20;6:33-4 - PubMed
  30. Antimicrob Agents Chemother. 2007 Feb;51(2):495-502 - PubMed
  31. Acta Pol Pharm. 2013 Sep-Oct;70(5):869-72 - PubMed
  32. Pharmacotherapy. 2013 Oct;33(10):1117-25 - PubMed
  33. Clin Infect Dis. 2013 Dec;57(12):e182-8 - PubMed
  34. Antimicrob Agents Chemother. 2015 Feb;59(2):1246-51 - PubMed
  35. Med Mycol Case Rep. 2014 Oct 05;6:51-4 - PubMed
  36. J Antimicrob Chemother. 2012 Sep;67(9):2274-82 - PubMed
  37. Antimicrob Agents Chemother. 2013 Jul;57(7):3420-3 - PubMed
  38. BMC Res Notes. 2015 Sep 29;8:491 - PubMed
  39. Transpl Infect Dis. 2015 Apr;17(2):250-8 - PubMed

Publication Types